Skip to main content

Peer Review reports

From: Clinical significance of low expression of CADM3 in breast cancer and preliminary exploration of related mechanisms

Original Submission
14 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Jun 2023 Reviewed Reviewer Report
12 Jun 2023 Reviewed Reviewer Report
13 Aug 2023 Author responded Author comments - Bo Chen
Resubmission - Version 4
13 Aug 2023 Submitted Manuscript version 4
3 Sep 2023 Author responded Author comments - Bo Chen
Resubmission - Version 5
3 Sep 2023 Submitted Manuscript version 5
9 Sep 2023 Author responded Author comments - Bo Chen
Resubmission - Version 6
9 Sep 2023 Submitted Manuscript version 6
21 Dec 2023 Reviewed Reviewer Report
2 Jan 2024 Author responded Author comments - Bo Chen
Resubmission - Version 7
2 Jan 2024 Submitted Manuscript version 7
7 Jan 2024 Author responded Author comments - Bo Chen
Resubmission - Version 8
7 Jan 2024 Submitted Manuscript version 8
15 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
12 Mar 2024 Editorially accepted
21 Mar 2024 Article published 10.1186/s12885-024-12114-y

You can find further information about peer review here.

Back to article page